首页
数据库
关于我们
联系我们
您当前的位置： 首页 > 数据库
所属年份
2008 2017 2018 2019 2020 2021 2022 2023 2024
到
2008 2017 2018 2019 2020 2021 2022 2023 2024
检索 清除
手术分类
  • 全部（1880）
  • 腹部手术（323）
  • 胸科手术（41）
  • 血管手术（5）
  • 心脏手术（56）
  • 神经外科（4）
  • 头颈部（35）
  • 骨科（78）
  • 泌尿外科（0）
  • 妇产手术（56）
  • 日间手术（26）
  • 手术室外（0）
  • 创伤和烧伤（0）
  • 非心脏手术（410）
  • 老年（0）
  • 小儿新生儿（126）
  • 特殊患者（42）
  • 未说明手术类型（678）
阶段管理
  • 术前宣教（21）
  • 术前评估（33）
  • 术前用药（15）
  • 术前禁食水（12）
  • 麻醉选择（21）
  • 麻醉用药（10）
  • 术中监测（23）
  • 液体管理（14）
  • 血液保护（3）
  • 体温管理（8）
  • 术后疼痛（43）
  • POD（8）
  • PONV（10）
  • 术后康复（50）
  • 特殊情况（43）
  • 术前肠道准备（9）
排序：
发表时间 阅读量
Array ( [id] => 470 [catid] => 243 [title] => Patient Blood Management for Neonates and Children undergoing Cardiac Surgery: 2019 NATA guidelines [thumb] => [keywords] => [description] => [hits] => [uid] => 1 [author] => 系统管理员 [status] => 9 [url] => https://www.anes-guide.com/show/470.html [link_id] => 0 [tableid] => 0 [inputip] => 14.105.95.222 [inputtime] => 2024-01-11 15:12:40 [updatetime] => 2024-01-11 15:12:40 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => [demo_url] => [zjpjff] => GRADE [zjfj] => [tjqd] => [nianfen] => 2019 [guojia] => the Network for the Advancement of Patient Blood M [pdf] => [tjyjyw] => [lyyw] => We recommend conventional ultrafiltration or ≥ 10 min of modified ultrafiltration for neonates and infants undergoing cardiac surgery with CPB. (1B) [laiyuan] => 建议对接受体外循环心脏手术的新生儿和婴儿进行常规超滤或≥10min的改良超滤 （证据等级：中；推荐强度：强推荐） [znzldj] => B [_inputtime] => 1704957160 [_updatetime] => 1704957160 [_nrjc] => [_nrsh] => )
推荐意见
建议对接受体外循环心脏手术的新生儿和婴儿进行常规超滤或≥10min的改良超滤 （证据等级：中；推荐强度：强推荐）

We recommend conventional ultrafiltration or ≥ 10 min of modified ultrafiltration for neonates and infants undergoing cardiac surgery with CPB. (1B)

证据评价方法：GRADE

指南质量等级：B

年份：2019

国家：the Network for the Advancement of Patient Blood M

来源 Patient Blood Management for Neonates and Children undergoing Cardiac Surgery: 2019 NATA guidelines
阅读
Array ( [id] => 471 [catid] => 243 [title] => Patient Blood Management for Neonates and Children undergoing Cardiac Surgery: 2019 NATA guidelines [thumb] => [keywords] => [description] => [hits] => [uid] => 1 [author] => 系统管理员 [status] => 9 [url] => https://www.anes-guide.com/show/471.html [link_id] => 0 [tableid] => 0 [inputip] => 14.105.95.222 [inputtime] => 2024-01-11 15:12:40 [updatetime] => 2024-01-11 15:12:40 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => [demo_url] => [zjpjff] => GRADE [zjfj] => [tjqd] => [nianfen] => 2019 [guojia] => the Network for the Advancement of Patient Blood M [pdf] => [tjyjyw] => [lyyw] => We recommend colloids (e.g. albumin) should be preferred over crystalloids for clear priming in children undergoing cardiac surgery. (1C) [laiyuan] => 推荐对于接受心脏手术的儿童，预冲液胶体（如白蛋白）应优于晶体液。（证据等级：低；推荐强度：强推荐） [znzldj] => B [_inputtime] => 1704957160 [_updatetime] => 1704957160 [_nrjc] => [_nrsh] => )
推荐意见
推荐对于接受心脏手术的儿童，预冲液胶体（如白蛋白）应优于晶体液。（证据等级：低；推荐强度：强推荐）

We recommend colloids (e.g. albumin) should be preferred over crystalloids for clear priming in children undergoing cardiac surgery. (1C)

证据评价方法：GRADE

指南质量等级：B

年份：2019

国家：the Network for the Advancement of Patient Blood M

来源 Patient Blood Management for Neonates and Children undergoing Cardiac Surgery: 2019 NATA guidelines
阅读
Array ( [id] => 472 [catid] => 243 [title] => Patient Blood Management for Neonates and Children undergoing Cardiac Surgery: 2019 NATA guidelines [thumb] => [keywords] => [description] => [hits] => [uid] => 1 [author] => 系统管理员 [status] => 9 [url] => https://www.anes-guide.com/show/472.html [link_id] => 0 [tableid] => 0 [inputip] => 14.105.95.222 [inputtime] => 2024-01-11 15:12:40 [updatetime] => 2024-01-11 15:12:40 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => [demo_url] => [zjpjff] => GRADE [zjfj] => [tjqd] => [nianfen] => 2019 [guojia] => the Network for the Advancement of Patient Blood M [pdf] => [tjyjyw] => [lyyw] => We suggest the addition of red blood cells to maintain a hematocrit > 24% during CPB based on the estimation of the degree of hemodilution related to CPB prime and cardioplegia. (2C) [laiyuan] => 根据体外循环预冲液和停跳液对血液稀释程度的评估，我们建议在体外循环期间补充红细胞，以保持血细胞比容大于24%。（证据等级：低；推荐强度：弱推荐） [znzldj] => B [_inputtime] => 1704957160 [_updatetime] => 1704957160 [_nrjc] => [_nrsh] => )
推荐意见
根据体外循环预冲液和停跳液对血液稀释程度的评估，我们建议在体外循环期间补充红细胞，以保持血细胞比容大于24%。（证据等级：低；推荐强度：弱推荐）

We suggest the addition of red blood cells to maintain a hematocrit > 24% during CPB based on the estimation of the degree of hemodilution related to CPB prime and cardioplegia. (2C)

证据评价方法：GRADE

指南质量等级：B

年份：2019

国家：the Network for the Advancement of Patient Blood M

来源 Patient Blood Management for Neonates and Children undergoing Cardiac Surgery: 2019 NATA guidelines
阅读
Array ( [id] => 473 [catid] => 243 [title] => Patient Blood Management for Neonates and Children undergoing Cardiac Surgery: 2019 NATA guidelines [thumb] => [keywords] => [description] => [hits] => [uid] => 1 [author] => 系统管理员 [status] => 9 [url] => https://www.anes-guide.com/show/473.html [link_id] => 0 [tableid] => 0 [inputip] => 14.105.95.222 [inputtime] => 2024-01-11 15:12:40 [updatetime] => 2024-01-11 15:12:40 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => [demo_url] => [zjpjff] => GRADE [zjfj] => [tjqd] => [nianfen] => 2019 [guojia] => the Network for the Advancement of Patient Blood M [pdf] => [tjyjyw] => [lyyw] => We suggest the addition of fresh frozen plasma to the CPB prime in neonates (< 30 days) undergoing cardiac surgery with cardiopulmonary bypass. (2C) [laiyuan] => 建议对接受心肺旁路手术的新生儿（小于30天）在体外循环预冲液中加新鲜冰冻血浆（FFP）。（证据等级：低；推荐强度：弱推荐） [znzldj] => B [_inputtime] => 1704957160 [_updatetime] => 1704957160 [_nrjc] => [_nrsh] => )
推荐意见
建议对接受心肺旁路手术的新生儿（小于30天）在体外循环预冲液中加新鲜冰冻血浆（FFP）。（证据等级：低；推荐强度：弱推荐）

We suggest the addition of fresh frozen plasma to the CPB prime in neonates (< 30 days) undergoing cardiac surgery with cardiopulmonary bypass. (2C)

证据评价方法：GRADE

指南质量等级：B

年份：2019

国家：the Network for the Advancement of Patient Blood M

来源 Patient Blood Management for Neonates and Children undergoing Cardiac Surgery: 2019 NATA guidelines
阅读
Array ( [id] => 474 [catid] => 243 [title] => Patient Blood Management for Neonates and Children undergoing Cardiac Surgery: 2019 NATA guidelines [thumb] => [keywords] => [description] => [hits] => [uid] => 1 [author] => 系统管理员 [status] => 9 [url] => https://www.anes-guide.com/show/474.html [link_id] => 0 [tableid] => 0 [inputip] => 14.105.95.222 [inputtime] => 2024-01-11 15:12:40 [updatetime] => 2024-01-11 15:12:40 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => [demo_url] => [zjpjff] => GRADE [zjfj] => [tjqd] => [nianfen] => 2019 [guojia] => the Network for the Advancement of Patient Blood M [pdf] => [tjyjyw] => [lyyw] => We recommend the implementation of miniaturized CPB for neonates and infants in order to reduce the effects of hemodilution and likelihood of transfusion. (1C) [laiyuan] => 建议对新生儿和婴儿实现体外循环小型化，以减少血液稀释的影响和输血的可能性。（证据等级：低；推荐强度：强推荐） [znzldj] => B [_inputtime] => 1704957160 [_updatetime] => 1704957160 [_nrjc] => [_nrsh] => )
推荐意见
建议对新生儿和婴儿实现体外循环小型化，以减少血液稀释的影响和输血的可能性。（证据等级：低；推荐强度：强推荐）

We recommend the implementation of miniaturized CPB for neonates and infants in order to reduce the effects of hemodilution and likelihood of transfusion. (1C)

证据评价方法：GRADE

指南质量等级：B

年份：2019

国家：the Network for the Advancement of Patient Blood M

来源 Patient Blood Management for Neonates and Children undergoing Cardiac Surgery: 2019 NATA guidelines
阅读
Array ( [id] => 475 [catid] => 243 [title] => Patient Blood Management for Neonates and Children undergoing Cardiac Surgery: 2019 NATA guidelines [thumb] => [keywords] => [description] => [hits] => [uid] => 1 [author] => 系统管理员 [status] => 9 [url] => https://www.anes-guide.com/show/475.html [link_id] => 0 [tableid] => 0 [inputip] => 14.105.95.222 [inputtime] => 2024-01-11 15:12:40 [updatetime] => 2024-01-11 15:12:40 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => [demo_url] => [zjpjff] => GRADE [zjfj] => [tjqd] => [nianfen] => 2019 [guojia] => the Network for the Advancement of Patient Blood M [pdf] => [tjyjyw] => [lyyw] => Lysine analogs (either TXA or EACA) should be preferred over aprotinin in neonates and children undergoing cardiac surgery with CPB. (2C) [laiyuan] => 对于接受体外循环心脏手术的新生儿和儿童，应首选赖氨酸类似物（氨甲环酸（TXA）或氨基乙酸（EACA）），而不是阿普罗宁。（证据等级：低；推荐强度：弱推荐） [znzldj] => B [_inputtime] => 1704957160 [_updatetime] => 1704957160 [_nrjc] => [_nrsh] => )
推荐意见
对于接受体外循环心脏手术的新生儿和儿童，应首选赖氨酸类似物（氨甲环酸（TXA）或氨基乙酸（EACA）），而不是阿普罗宁。（证据等级：低；推荐强度：弱推荐）

Lysine analogs (either TXA or EACA) should be preferred over aprotinin in neonates and children undergoing cardiac surgery with CPB. (2C)

证据评价方法：GRADE

指南质量等级：B

年份：2019

国家：the Network for the Advancement of Patient Blood M

来源 Patient Blood Management for Neonates and Children undergoing Cardiac Surgery: 2019 NATA guidelines
阅读
Array ( [id] => 476 [catid] => 243 [title] => Patient Blood Management for Neonates and Children undergoing Cardiac Surgery: 2019 NATA guidelines [thumb] => [keywords] => [description] => [hits] => [uid] => 1 [author] => 系统管理员 [status] => 9 [url] => https://www.anes-guide.com/show/476.html [link_id] => 0 [tableid] => 0 [inputip] => 14.105.95.222 [inputtime] => 2024-01-11 15:12:40 [updatetime] => 2024-01-11 15:12:40 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => [demo_url] => [zjpjff] => GRADE [zjfj] => [tjqd] => [nianfen] => 2019 [guojia] => the Network for the Advancement of Patient Blood M [pdf] => [tjyjyw] => [lyyw] => We recommend against the administration of high doses of lysine analogs (either TXA or EACA) due to the risk of clinical seizures. (1C) [laiyuan] => 由于存在临床癫痫发作的风险，建议不要使用大剂量赖氨酸类似物（氨甲环酸（TXA）或氨基乙酸（EACA））。（证据等级：低；推荐强度：强推荐） [znzldj] => B [_inputtime] => 1704957160 [_updatetime] => 1704957160 [_nrjc] => [_nrsh] => )
推荐意见
由于存在临床癫痫发作的风险，建议不要使用大剂量赖氨酸类似物（氨甲环酸（TXA）或氨基乙酸（EACA））。（证据等级：低；推荐强度：强推荐）

We recommend against the administration of high doses of lysine analogs (either TXA or EACA) due to the risk of clinical seizures. (1C)

证据评价方法：GRADE

指南质量等级：B

年份：2019

国家：the Network for the Advancement of Patient Blood M

来源 Patient Blood Management for Neonates and Children undergoing Cardiac Surgery: 2019 NATA guidelines
阅读
Array ( [id] => 477 [catid] => 243 [title] => Patient Blood Management for Neonates and Children undergoing Cardiac Surgery: 2019 NATA guidelines [thumb] => [keywords] => [description] => [hits] => [uid] => 1 [author] => 系统管理员 [status] => 9 [url] => https://www.anes-guide.com/show/477.html [link_id] => 0 [tableid] => 0 [inputip] => 14.105.95.222 [inputtime] => 2024-01-11 15:12:40 [updatetime] => 2024-01-11 15:12:40 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => [demo_url] => [zjpjff] => GRADE [zjfj] => [tjqd] => [nianfen] => 2019 [guojia] => the Network for the Advancement of Patient Blood M [pdf] => [tjyjyw] => [lyyw] => We recommend prophylactic administration of lysine analogs (either TXA or EACA) for all neonates and children undergoing surgery with CPB in order to reduce perioperative bleeding and transfusion. (1B) [laiyuan] => 推荐所有接受体外循环（CPB）手术的新生儿和儿童预防性使用赖氨酸类似物（氨甲环酸或氨基己酸），以减少围手术期出血和输血。（证据等级：中；推荐强度：强推荐） [znzldj] => B [_inputtime] => 1704957160 [_updatetime] => 1704957160 [_nrjc] => [_nrsh] => )
推荐意见
推荐所有接受体外循环（CPB）手术的新生儿和儿童预防性使用赖氨酸类似物（氨甲环酸或氨基己酸），以减少围手术期出血和输血。（证据等级：中；推荐强度：强推荐）

We recommend prophylactic administration of lysine analogs (either TXA or EACA) for all neonates and children undergoing surgery with CPB in order to reduce perioperative bleeding and transfusion. (1B)

证据评价方法：GRADE

指南质量等级：B

年份：2019

国家：the Network for the Advancement of Patient Blood M

来源 Patient Blood Management for Neonates and Children undergoing Cardiac Surgery: 2019 NATA guidelines
阅读
Array ( [id] => 478 [catid] => 243 [title] => Patient Blood Management for Neonates and Children undergoing Cardiac Surgery: 2019 NATA guidelines [thumb] => [keywords] => [description] => [hits] => [uid] => 1 [author] => 系统管理员 [status] => 9 [url] => https://www.anes-guide.com/show/478.html [link_id] => 0 [tableid] => 0 [inputip] => 14.105.95.222 [inputtime] => 2024-01-11 15:12:40 [updatetime] => 2024-01-11 15:12:40 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => [demo_url] => [zjpjff] => GRADE [zjfj] => [tjqd] => [nianfen] => 2019 [guojia] => the Network for the Advancement of Patient Blood M [pdf] => [tjyjyw] => [lyyw] => We recommend against routine preoperative assessment of coagulation tests (e.g. aPTT, PTT, fibrinogen level) and platelet count in infants and children without a bleeding history prior to cardiac surgery. (1C) [laiyuan] => 不推荐在心脏手术前对无出血史的婴幼儿进行常规术前凝血检测（如 aPTT、PTT、纤维蛋白原水平）和血小板计数评估 。（证据等级：低；推荐强度：强推荐） [znzldj] => B [_inputtime] => 1704957160 [_updatetime] => 1704957160 [_nrjc] => [_nrsh] => )
推荐意见
不推荐在心脏手术前对无出血史的婴幼儿进行常规术前凝血检测（如 aPTT、PTT、纤维蛋白原水平）和血小板计数评估 。（证据等级：低；推荐强度：强推荐）

We recommend against routine preoperative assessment of coagulation tests (e.g. aPTT, PTT, fibrinogen level) and platelet count in infants and children without a bleeding history prior to cardiac surgery. (1C)

证据评价方法：GRADE

指南质量等级：B

年份：2019

国家：the Network for the Advancement of Patient Blood M

来源 Patient Blood Management for Neonates and Children undergoing Cardiac Surgery: 2019 NATA guidelines
阅读
Array ( [id] => 479 [catid] => 243 [title] => Patient Blood Management for Neonates and Children undergoing Cardiac Surgery: 2019 NATA guidelines [thumb] => [keywords] => [description] => [hits] => [uid] => 1 [author] => 系统管理员 [status] => 9 [url] => https://www.anes-guide.com/show/479.html [link_id] => 0 [tableid] => 0 [inputip] => 14.105.95.222 [inputtime] => 2024-01-11 15:12:40 [updatetime] => 2024-01-11 15:12:40 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => [demo_url] => [zjpjff] => GRADE [zjfj] => [tjqd] => [nianfen] => 2019 [guojia] => the Network for the Advancement of Patient Blood M [pdf] => [tjyjyw] => [lyyw] => We suggest considering preoperative EPO only in specific needy situations (e.g. Jehovah Witnesses). (2C) [laiyuan] => 建议只有在特殊情况下才考虑术前促红细胞生成素（EPO）。（证据等级：低；推荐强度：弱推荐） [znzldj] => B [_inputtime] => 1704957160 [_updatetime] => 1704957160 [_nrjc] => [_nrsh] => )
推荐意见
建议只有在特殊情况下才考虑术前促红细胞生成素（EPO）。（证据等级：低；推荐强度：弱推荐）

We suggest considering preoperative EPO only in specific needy situations (e.g. Jehovah Witnesses). (2C)

证据评价方法：GRADE

指南质量等级：B

年份：2019

国家：the Network for the Advancement of Patient Blood M

来源 Patient Blood Management for Neonates and Children undergoing Cardiac Surgery: 2019 NATA guidelines
阅读

地址：甘肃省兰州市七里河区瓜州路418号

邮编：730050

电话：0931-2687109

商务合作热线：0931-2687106

备案号：陇ICP备17005383号-1 联网备案号：62010302000288

技术支持：瑞秀科技